BioNTech SE
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- pharmaceutical industry [1]
- Company / filing name
- BioNTech SE [2]
- Headquarters location
- Mainz [1]
- Founded
- 2008-06 [1]
- Legal form
- Societas Europaea [1]
- Leadership in background record
- Uğur Şahin [1]
- Founders
- Özlem Türeci; Uğur Şahin [1]
- Official website
- biontech.de ↗ [1]
- Employees
- 1,300 · reported year 2019 [1]
- Annual revenue
- EUR 108,589,000 · reported year 2019 [1]
- ISIN (reported securities)
- US09075V1026 [1]
- CIK
- 1776985 [2]
- Country in background record
- Germany [1]
- Symbols / exchanges
- BNTX (Nasdaq) [2]
Company positioning and business
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. [3]
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. [3]
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. [3]
Background text: Wikipedia contributors, BioNTech. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Management and corporate governance
The Wikidata background record identifies Uğur Şahin in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [1]
Understanding company scale
Employees: 1,300 · reported year 2019. [1]
Annual revenue: EUR 108,589,000 · reported year 2019. [1]
Financial year, securities and disclosures
Listed securities: BNTX (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Founding / inception date recorded in Wikidata. [1]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was BioNTech SE founded?
Founded: 2008-06. The linked source provides the background record. [1]
Where is the headquarters of BioNTech SE?
Headquarters location: Mainz. The linked source provides the background record. [1]
Which business sectors are recorded for BioNTech SE?
Business sectors: pharmaceutical industry. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — BioNTech (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.